For some types of cancer, the human body itself complicates adequate treatment. Connective tissue and the immune system then build a sort of "defensive wall" around the tumor, through which chemotherapy drugs cannot penetrate. ...
Mar 11, 2022
0
11
An immunotherapy drug called pembrolizumab has been shown to significantly reduce disease recurrence in patients with the most aggressive type of breast cancer, according to results from a phase III clinical trial led by ...
Feb 10, 2022
0
13
The blood-brain barrier keeps foreign substances from entering the brain. That's good when it comes to toxins and germs, but it makes treating tumors in the brain trickier. By shielding the brain from things that would harm ...
Jan 26, 2022
0
6
A team of investigators has discovered a genomic variant that may help clinicians predict which patients will experience cardiotoxicity from a widely used chemotherapy drug, according to a Northwestern Medicine study published ...
Jan 4, 2022
0
35
A team of faculty from the University of Michigan Center of Academic Innovation, School of Nursing and College of Pharmacy designed an innovative way to teach nursing and pharmacy students about the intricacies of chemotherapy.
Dec 23, 2021
0
7
Pancreatic cancer is extremely difficult to treat. By the time it is detected, the cancer often has reached an advanced stage, and patients usually do not survive longer than one year after diagnosis. An aggressive chemotherapy ...
Dec 1, 2021
0
42
Previous research has found that chemotherapy can trigger muscle loss in people living with cancer, but a new study out of Penn State found it may also affect the way the body builds new muscle—and at lower doses than previously ...
Nov 22, 2021
0
3
Immunotherapy is a promising strategy to treat cancer by stimulating the body's own immune system to destroy tumor cells, but it only works for a handful of cancers. MIT researchers have now discovered a new way to jump-start ...
Oct 19, 2021
0
272
The U.S. Food and Drug Administration has approved Roche's Tecentriq as adjuvant treatment following surgery and platinum-based chemotherapy, for adults with Stage II-IIIA non-small cell lung cancer, as determined by an FDA-approved ...
Oct 18, 2021
0
3
It's one of the most heartbreaking things Adam Green, MD, sees as a pediatric oncologist: children who beat their cancer, only to see an incurable brain tumor arise five years later.
Sep 28, 2021
0
64
